Tech Company Financing Transactions

Delphia Therapeutics Funding Round

On 5/2/2024, Delphia Therapeutics raised $67 million in Series A investment from Alexandria Venture Investments, GV and Nextech Invest.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Healthcare Services

Mailing Address

One Kendall Sq., Bldg. 200 001
Cambridge, MA 02139
USA

Phone

Undisclosed

Website

www.delphiatx.com

Email Address

[email protected]

Overview

Delphia is pioneering an entirely new field of cancer biology -- activation lethality -- to advance a new treatment paradigm and improve the lives of cancer patients. Over the past few decades, there have been dramatic advances in therapeutics that directly drug driver mutations in oncogenes.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kevin Marks

        

Chief Technical Officer

Mike Dillon

        

VP - Bus. Development

Michael Acker

        

VP - Bus. Development

Aimee Usera

        

VP - Operations

Bryan Gutierrez

        

Browse more venture capital transactions:

Prev: 5/2/2024: Apex venture capital transaction
Next: 5/2/2024: Mimic venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary